Impact of maternal psoriasis on adverse maternal and neonatal outcomes: a systematic review and meta-analysis

Table 1 Characteristics of included studies on the impact of psoriasis on maternal and neonatal outcomes

Reference	Author	Publication year	Study type	N psoriasis	study period	Continent	Country	Quality score	Quality
[25]	Seeger GD, 2007	2007	Prospective	4262	1997–2002	America	USA	20	High
[26]	Ben-Dav, 2008	2008	Retrospective	84	1988–2004	Asia	Israel	14	Low
[27]	Cohen-Barak E, 2010	2010	Retrospective	35	1999–2009	Asia	Israel	15	Low
[28]	Lima XT, 2011	2011	Retrospective	122	1999–2009	America	USA	18	High
[29]	Yang YW, 2011	2011	Retrospective	1463		Asia	China	14	Low
[30]	Harder E, 2014	2014	Prospective	2553	1996–2003	Europe	Denmark	10	Low
[31]	Amiri, 2016	2016	Prospective	180	2005–2015	America	USA	16	High
[32]	Bandoli G, 2017	2017	Prospective	330	2009–2015	America	USA	17	High
[33]	Chiou MJ, 2017	2017	Retrospective	3669	2001–2012	Asia	China	18	High
[34]	Broms G, 2018	2018	Prospective	8097	2007–2012	Europe	Denmark	16	High
[35]	Polachek A, 2018	2018	Prospective	74		America	Canada	16	High
[36]	Remaeus K, 2019	2019	Retrospective	541	1997–2014	Europe	Sweden	18	High
[37]	Smith CF, 2019	2019	Prospective	117	2004–2018	America	USA	15	Low
[38]	Strouse J, 2019	2019	Retrospective	10,975	2007–2012	America	USA	18	High
[39]	Bandoli G, 2020	2020	Retrospective	1255	2007–2012	America	USA	10	Low
[40]	Lambe M, 2020	2020	Retrospective	33,488	1992–2009	Europe	Sweden	11	Low
[41]	Huang YH, 2020	2020	Retrospective	4058	2001–2012	Asia	Taiwan	15	Low
[42]	Remaeus K, 2022	2022	Retrospective	921	2007–2017	Europe	Swedish	20	High
[43]	Gangbe EM, 2021	2021	Retrospective	419		America	Canada	17	High
[44]	Johansen CB, 2022	2022	Retrospective	6282	2004–2017	Europe	Denmark	21	High
[45]	Krim D, 2021	2021	Retrospective	3737	1999–2015	America	USA	20	High

ISSN: 1471-2393